• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Implementing a point-of-care test for {beta}-human chorionic gonadotropin testing within an abortion service

Why was change needed?

There are several scenarios within abortion care in which the measurement of serum beta-human chorionic gonadotropin (β-hCG) levels is useful or necessary. These include the management of pregnancy of unknown location, diagnosis of miscarriage or gestational trophoblastic disease, and confirmation that a medical abortion is complete as part of the protocol for very early medical abortion (VEMA).1–4

In NHS Lothian (Edinburgh and surrounding region), the abortion service based in Chalmers Sexual Health Centre provides abortion for approximately 3500 patients per year and operates a telemedicine-based service.5 6 Patients can also have an in-person consultation, with or without an ultrasound scan, if preferred or indicated.

As is the case for many community services across the UK, there is no laboratory on site, which means that any serum β-hCG samples require transportation to the Royal Infirmary of Edinburgh…

Read the full article ›

Posted in: Journal Article Abstracts on 01/17/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice